Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Krogsgaard

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma PrognosisMatjaz Vogelsang, Carlos N Martinez, Justin Rendleman, et al.
Vaccine|October 15, 2025
TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targetsEmma Falling Iversen, Anna H F Rahimic, Giacomo S Frattari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 9, 2016
Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell SubsetsDuane Moogk, Shi Zhong, Zhiya Yu, et al.
Breast Cancer Research and Treatment|September 19, 2020
Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatmentJiehui Deng, Aatish Thennavan, Suhagi Shah, et al.
Journal of Translational Medicine|April 3, 2018
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitorsMichael F Gowen, Keith M Giles, Danny Simpson, et al.
Research Square|July 9, 2025
SARS-CoV-2 vaccination unmasks distinct immune dysfunctions across lymphoma subtypes and therapiesYogambigai Velmurugu, Anna Halling Folkmar Rahimic, Ryan Curtin, et al.
Journal of Medical Genetics|January 22, 2015
Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanomaJustin Rendleman, Matjaz Vogelsang, Anuj Bapodra, et al.
Cancers|January 11, 2024
Kinase Insert Domain Receptor Q472H Pathogenic Germline Variant Impacts Melanoma Tumor Growth and Patient Treatment OutcomesMilad Ibrahim, Irineu Illa-Bochaca, Faisal Fa'ak, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2013
T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapyShi Zhong, Karolina Malecek, Laura A Johnson, et al.
Journal of Translational Medicine|December 11, 2014
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapyDuane Moogk, Ines Pires da Silva, Michelle W Ma, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma PrognosisMatjaz Vogelsang, Carlos N Martinez, Justin Rendleman, et al.
Vaccine|October 15, 2025
TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targetsEmma Falling Iversen, Anna H F Rahimic, Giacomo S Frattari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 9, 2016
Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell SubsetsDuane Moogk, Shi Zhong, Zhiya Yu, et al.
Breast Cancer Research and Treatment|September 19, 2020
Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatmentJiehui Deng, Aatish Thennavan, Suhagi Shah, et al.
Journal of Translational Medicine|April 3, 2018
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitorsMichael F Gowen, Keith M Giles, Danny Simpson, et al.
Research Square|July 9, 2025
SARS-CoV-2 vaccination unmasks distinct immune dysfunctions across lymphoma subtypes and therapiesYogambigai Velmurugu, Anna Halling Folkmar Rahimic, Ryan Curtin, et al.
Journal of Medical Genetics|January 22, 2015
Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanomaJustin Rendleman, Matjaz Vogelsang, Anuj Bapodra, et al.
Cancers|January 11, 2024
Kinase Insert Domain Receptor Q472H Pathogenic Germline Variant Impacts Melanoma Tumor Growth and Patient Treatment OutcomesMilad Ibrahim, Irineu Illa-Bochaca, Faisal Fa'ak, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2013
T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapyShi Zhong, Karolina Malecek, Laura A Johnson, et al.
Journal of Translational Medicine|December 11, 2014
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapyDuane Moogk, Ines Pires da Silva, Michelle W Ma, et al.
Pageof 7